药品名称CELLCEPT
申请号050722产品号001
活性成分MYCOPHENOLATE MOFETIL市场状态处方药
剂型或给药途径CAPSULE;ORAL规格250MG
治疗等效代码AB参比药物
批准日期1995/05/03申请机构ROCHE PALO ALTO LLC
化学类型New molecular entity (NME)审评分类Priority review drug
与本品相关的专利信息(来自橙皮书Orange Book)
专利号专利过期日是否化合物专利是否产品专利专利用途代码专利下载
历史专利信息
47539352009/05/03YYPDF格式
与本品相关的市场独占权保护信息
独占权代码失效日期
历史市场独占权保护信息
与药品注册相关的信息
申请号修订号审批结论公开文档类型文档创建时间获取文档
050722034APLetter2015/11/19下载
050722033APLabel2015/07/13下载
050722033APLetter2015/07/14下载
050722031APLabel2013/10/01下载
050722031APLetter2013/10/01下载
050722030APLabel2013/10/01下载
050722030APLetter2013/10/01下载
050722028APLetter2012/06/26下载
050722028APMedication Guide2012/06/26下载
050722028APLabel2012/06/26下载
050722026APLetter2012/06/12下载
050722026APLabel2012/06/18下载
050722026APMedication Guide2012/06/18下载
050722024APLabel2009/10/14下载
050722024APLetter2009/11/09下载
050722022APLetter2012/09/27下载
050722021APLetter2009/06/23下载
050722021APLabel2009/06/24下载
050722020APLetter2009/03/05下载
050722020APLabel2009/03/19下载
050722019APLetter2008/12/24下载
050722019APLabel2009/01/02下载
050722018APLetter2008/05/15下载
050722018APLabel2008/05/16下载
050722016APLetter2007/09/25下载
050722016APLabel2007/09/26下载
050722015APLabel2007/12/27下载
050722015APLetter2008/01/09下载
050722013APLetter2005/10/19下载
050722013APLabel2005/10/19下载
050722009APReview2004/10/08下载
050722008APLabel2003/02/28下载
050722008APLetter2003/03/10下载
050722007APLetter2000/12/20下载
050722007APLabel2000/12/20下载
050722007APReview2000/12/22下载
050722006APReview2004/10/08下载
050722005APReview2000/07/28下载
050722005APLetter2000/07/28下载
050722005APLabel2000/07/28下载
050722004APReview2004/10/08下载
050722000APOther Important Information from FDA2009/07/15下载
050722000APMedication Guide2009/10/19下载
050722000APOther2012/09/27下载
药品注册审批历史信息
申请号修订号审批结论审批日期审批内容
050722034AP2015/11/13Supplement
050722033AP2015/07/09Labeling Revision
050722032AP2014/01/23Manufacturing Change or Addition
050722031AP2013/09/27Labeling Revision
050722030AP2013/09/27Labeling Revision
050722028AP2012/06/22Labeling Revision
050722027AP2013/02/14Manufacturing Change or Addition
050722026AP2012/06/08Labeling Revision
050722024AP2009/10/08Labeling Revision
050722022AP2012/09/25Labeling Revision
050722021AP2009/06/18Labeling Revision
050722020AP2009/02/27Labeling Revision
050722019AP2008/12/15Labeling Revision
050722018AP2008/05/09Labeling Revision
050722016AP2007/09/21Labeling Revision
050722015AP2007/12/20Labeling Revision
050722013AP2005/10/17Labeling Revision
050722010AP2002/05/31Manufacturing Change or Addition
050722009AP2001/11/14Package Change
050722008AP2003/02/28Labeling Revision
050722007AP2000/12/20Patient Population Altered
050722006AP2000/05/15Control Supplement
050722005AP2000/07/28New or Modified Indication
050722004AP2000/07/27Labeling Revision
050722003AP1998/04/13Manufacturing Change or Addition
050722002AP1998/02/11New or Modified Indication
050722001AP1997/06/12Control Supplement
050722000AP1995/05/03Approval